- Consumables
- Instruments
- Software
- Services
RNA Analysis Transcriptomics market is estimated to be valued at USD 8,648.3 Million in 2021 and is poised to grow at a significant CAGR of 16.9% over 2022-2028. Transcriptomics is the study of the RNA transcripts set produced by the organism’s genome. Transcriptome analysis allows researchers to learn about the sequence and function of DNA. The increased demand for specific genes, quantification of multiplexed RNA, various assay technologies, increased need for genetic testing and personalized medicine and rise in genetic variation and genetic mutation incidences drive the rna analysis transcriptomics market demand. The Consumables segment is anticipated to grow at a significant CAGR over the forecast years owing to expanding pharmaceutical R&D activity, as well as increased government financing for life sciences research. For example, in March 2022, the Government of Canada allocated $13.8 million in government funding to deploy genomics through ten downstream processing R&D initiatives. The growing emphasis on biomarker development and toxicogenomic, as well as the growing interest in outsourcing services, are likely to provide substantial potential possibilities for companies in the global RNA analysis/transcriptomics market.
Key Developments:
In June 2022, Fluent BioSciences a private funded biotechnology company launched the PIPseqTM technology for single-cell RNA analysis in laboratories. In February 2022, QIAGEN leading global provider of Sample partnered with Singular Genomics Systems Inc. to get their QIAseq kits validated.
Rna Analysis Transcriptomics Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
16.9%
Largest Market
North American
Fastest Growing Market
Asia-Pacific
RNA Analysis Transcriptomics Market Dynamics
The growth of the global transcriptomics market is majorly driven by a surge in demand for personalized medicine. Personalized medicine has entered mainstream clinical practice and transformed how many diseases are detected, categorized, and treated. It has become a fundamental focus of study in the healthcare business. These developments are notably visible in cancer. The number of personalized medications, therapies, and diagnostic items has grown since 2006, according to the Personalized Medicine Coalition report (2017), and this trend is projected to continue in the future years. Moreover, market players focus on launching new products, acquisition, and collaboration. For instance, In 2020, Agilent Technologies leading life science company, launched its Sure Select XT HS2 RNA Reagent Kit.
North America Got Significant Share
RNA Analysis Transcriptomics Market
The RNA Analysis Transcriptomics market in North America is likely to hold the highest revenue share of in 2021 and same trend is expected over the forecast period due to increased emphasis on transcriptomics research, as well as significant investments in biopharmaceutical research and development. Furthermore, growing investment in pharmaceutical research and medication development is a crucial driver driving revenue growth in this region's industries. During the projection period, Asia Pacific is expected to have the quickest CAGR. Growing government and business funding are boosting biotechnology research in Asia Pacific countries.
Latin America
Europe
Asia Pacific
Middle East
North America
Rna Analysis Transcriptomics Market Segmentation
Type
Technology
- Microarrays
- qPCR
- Sequencing Technology
Application
- Drug Discovery
- Diagnostics and Disease Profiling
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The RNA analysis transcriptomics market is projected to expand at a CAGR of 16.9% during the forecast period
Agilent Technologies Inc., Bio-Rad Laboratories, F-Hoffmann La-Roche, Fluidigm Corporation, General Electric Company, Illuminia Inc., Merck & Co. Inc, Promega Corporation, Qiagen, Inc., Thermofisher Scientific .
North America is the fastest-growing region for RNA analysis transcriptomics market
Key Features of the Reports
- The report provides granular level information about the market size, regional market share and forecast from 2021-2027
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
| 1. Executive Summary |
| 2. Global RNA Analysis/ Transcriptomics Market Introduction |
| 2.1. Global RNA Analysis/ Transcriptomics Market – Taxonomy |
| 2.2. Global RNA Analysis/ Transcriptomics Market –Definitions |
| 2.2.1. By Type |
| 2.2.2. By Technology |
| 2.2.3. By Application |
| 2.2.4. By Region |
| 3. Global RNA Analysis/ Transcriptomics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global RNA Analysis/ Transcriptomics Market Dynamic Factors - Impact Analysis |
| 3.6. Global RNA Analysis/ Transcriptomics Market – Competition Landscape |
| 4. Global RNA Analysis/ Transcriptomics Market Analysis,2017-2021 and Forecast, 2022-2028 |
| 4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global RNA Analysis/ Transcriptomics Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1. Consumables |
| 5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Instruments |
| 5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Software |
| 5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Services |
| 5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global RNA Analysis/ Transcriptomics Market Forecast, By Technology, 2017-2021 and Forecast, 2021 – 2027 (Revenue, USD Mn) |
| 6.1. Microarrays |
| 6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. qPCR |
| 6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Sequencing Technology |
| 6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global RNA Analysis/ Transcriptomics Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1. Drug Discovery |
| 7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostics and Disease Profiling |
| 7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global RNA Analysis/ Transcriptomics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Region, 2022-2028 |
| 8.6.1. North America RNA Analysis/ Transcriptomics MarketAnalysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.7. By Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.7.1. Consumables |
| 8.7.2. Instruments |
| 8.7.3. Software |
| 8.7.4. Services |
| 8.8. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.8.1. Microarrays |
| 8.8.2. qPCR |
| 8.8.3. Sequencing Technology |
| 8.9. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.9.1. Drug Discovery |
| 8.9.2. Diagnostics and Disease Profiling |
| 8.9.3. Others |
| 8.10. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.10.1. USA |
| 8.10.2. Canada |
| 8.11. North America RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Country, 2022-2028 |
| 8.12. North America RNA Analysis/ Transcriptomics Market Dynamics – Trends |
| 9. Europe RNA Analysis/ Transcriptomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1. By Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Consumables |
| 9.1.2. Instruments |
| 9.1.3. Software |
| 9.1.4. Services |
| 9.2. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Microarrays |
| 9.2.2. qPCR |
| 9.2.3. Sequencing Technology |
| 9.3. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Drug Discovery |
| 9.3.2. Diagnostics and Disease Profiling |
| 9.3.3. Others |
| 9.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. Germany |
| 9.4.2. UK |
| 9.4.3. France |
| 9.4.4. Spain |
| 9.4.5. Italy |
| 9.4.6. Rest of Europe |
| 9.5. Europe RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Country, 2022-2028 |
| 9.6. Europe RNA Analysis/ Transcriptomics Market Dynamics – Trends |
| 10. Asia-Pacific RNA Analysis/ Transcriptomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 10.1. By Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Consumables |
| 10.1.2. Instruments |
| 10.1.3. Software |
| 10.1.4. Services |
| 10.2. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Microarrays |
| 10.2.2. qPCR |
| 10.2.3. Sequencing Technology |
| 10.3. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Drug Discovery |
| 10.3.2. Diagnostics and Disease Profiling |
| 10.3.3. Others |
| 10.4. Country Analysis2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Japan |
| 10.4.2. China |
| 10.4.3. India |
| 10.4.4. ASEAN |
| 10.4.5. Australia & New Zealand |
| 10.4.6. Rest of Asia-Pacific |
| 10.5. Asia-Pacific RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Country, 2022-2028 |
| 10.6. Asia-Pacific RNA Analysis/ Transcriptomics Market Dynamics – Trends |
| 11. Latin America RNA Analysis/ Transcriptomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 11.1. By Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Consumables |
| 11.1.2. Instruments |
| 11.1.3. Software |
| 11.1.4. Services |
| 11.2. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Microarrays |
| 11.2.2. qPCR |
| 11.2.3. Sequencing Technology |
| 11.3. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Drug Discovery |
| 11.3.2. Diagnostics and Disease Profiling |
| 11.3.3. Others |
| 11.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Brazil |
| 11.4.2. Mexico |
| 11.4.3. Argentina |
| 11.4.4. Rest of Latin America |
| 11.5. Latin America RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Country, 2022-2028 |
| 11.6. Latin America RNA Analysis/ Transcriptomics Market Dynamics – Trends |
| 12. Middle East and Africa RNA Analysis/ Transcriptomics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 12.1. By Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Consumables |
| 12.1.2. Instruments |
| 12.1.3. Software |
| 12.1.4. Services |
| 12.2. By Technology Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Microarrays |
| 12.2.2. qPCR |
| 12.2.3. Sequencing Technology |
| 12.3. By Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Drug Discovery |
| 12.3.2. Diagnostics and Disease Profiling |
| 12.3.3. Others |
| 12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Gulf Cooperation Council (GCC) Countries |
| 12.4.2. Israel |
| 12.4.3. South Africa |
| 12.4.4. Rest of MEA |
| 12.5. MEA RNA Analysis/ Transcriptomics Market - Opportunity Analysis Index, By Type, By Technology, By Application, and Country, 2022-2028 |
| 12.6. MEA RNA Analysis/ Transcriptomics Market Dynamics – Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, By Technology & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Agilent Technologies Inc. |
| 13.2.2. Bio-Rad Laboratories |
| 13.2.3. F-Hoffmann La-Roche |
| 13.2.4. Fluidigm Corporation |
| 13.2.5. General Electric Company |
| 13.2.6. Illuminia Inc. |
| 13.2.7. Merck & Co. Inc |
| 13.2.8. Promega Corporation |
| 13.2.9. Qiagen, Inc. |
| 13.2.10. Thermofisher Scientific . |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
- Agilent Technologies Inc.
- Bio-Rad Laboratories
- F-Hoffmann La-Roche
- Fluidigm Corporation
- General Electric Company
- Illuminia Inc.
- Merck & Co. Inc
- Promega Corporation
- Qiagen, Inc.
- Thermofisher Scientific .